3 Engineering Plastics Maker, Defence Optics Company and Hospitals Group Stocks With a Strong Future Roadmap: Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise
- November 13, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise: ROE of 12.1% to 23.7% and FY22 to FY26 revenue CAGR of 14.6% to 27.6%. Prices as of 12 Nov 2026.
Quick Answer
The three engineering plastic, defence and hospital stocks to watch are Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise. Their return on equity ranges from 12.1% to 23.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 27.6%. Shaily Engineering Plastics has the highest return on equity at 23.7%, while Paras Defence and Space Technologies has the fastest revenue growth at 27.6% a year. Prices are based on the 12 November 2026 close, and this article is educational, not investment advice.
Engineering plastic, defence and hospital stocks bring together companies with a visible plan for the years ahead. Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise cover an engineering plastics maker, a defence optics company and a hospitals group.
This list covers three engineering plastic, defence and hospital stocks with complete current figures: Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise. Every figure comes from the latest reported financials and the 12 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Engineering Plastic, Defence and Hospital Stocks?
Engineering plastic, defence and hospital stocks are listed companies that make engineered plastic parts for vehicles and appliances, build optics and electronics for defence and space programmes, and run large hospitals, clinics and pharmacies. Their earnings depend on vehicle and appliance demand, defence orders and patient volumes.
Engineering Plastic, Defence and Hospital Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Shaily Engineering Plastics | 3,123.8 | 13,693 | 77.5 | 35.6 | 23.7 | 0.25 |
| Paras Defence and Space Technologies | 1,304.4 | 10,193 | 106.3 | 48.1 | 12.1 | 0.04 |
| Apollo Hospitals Enterprise | 8,515 | 110,757 | 51.0 | 59.6 | 20.5 | 0.90 |
On valuation, Apollo Hospitals Enterprise trades at a P/E below the industry P/E, while Shaily Engineering Plastics and Paras Defence and Space Technologies trade above it, which reflects the growth the market already expects. Readers comparing engineering plastic, defence and hospital stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in engineering plastic, defence and hospital stocks can use the coming numbers to test whether growth is holding.
Why Do Engineering Plastic, Defence and Hospital Stocks Have a Strong Roadmap in India?
Engineering plastic, defence and hospital stocks have a strong roadmap in India because growing use of engineered plastics, rising defence and space spending and strong demand for quality hospital care keep widening the market for these companies.
- Engineering plastics. Makers replace metal with light parts.
- Defence optics. Programmes need advanced domestic systems.
- Hospitals. Families seek quality specialist care.
Why Shaily Engineering Plastics Features Among These Engineering Plastic, Defence and Hospital Stocks
Among the engineering plastic, defence and hospital stocks on this list, Shaily Engineering Plastics makes precision injection moulded plastic components, including parts for medical drug-delivery devices, consumer products and automobiles, mainly for global customers.
Revenue rose from Rs 577 crore in FY22 to Rs 998 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 35.3 crore in FY22 to Rs 170 crore in FY26, which works out to a compound annual growth rate of 48.2%.
In the June 2026 quarter, revenue grew 12.9% year on year to Rs 281 crore, while net profit rose 16.8% to Rs 48.0 crore. The company has a return on equity of 23.7%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 13,693 crore. The stock trades at a P/E of 77.5, above the industry P/E of 35.6.
Roadmap: The company is expanding in healthcare and consumer components, where global brands outsource complex moulding to trusted makers. Added capacity and new customer programmes support its order flow.
What to watch: Watch new customer programmes in drug-delivery devices and the pace of capacity additions.
Why Paras Defence and Space Technologies Features Among These Engineering Plastic, Defence and Hospital Stocks
Among the polymer parts, optics maker and healthcare group shares on this list, Paras Defence and Space Technologies makes optics and electro-optics, defence electronics, heavy engineering products and space optics, and serves the defence, space and homeland security markets.
In the June 2026 quarter, revenue grew 35.9% year on year to Rs 130 crore, while net profit rose 45.3% to Rs 20.7 crore. Revenue rose from Rs 186 crore in FY22 to Rs 493 crore in FY26, a compound annual growth rate of 27.6%.
Net profit grew from Rs 27.1 crore in FY22 to Rs 89.5 crore in FY26, which works out to a compound annual growth rate of 34.8%. The company has a return on equity of 12.1%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 10,193 crore. The stock trades at a P/E of 106.3, above the industry P/E of 48.1.
Roadmap: The company is among the few Indian private players in defence optics and has been adding capabilities in thermal imaging, anti-drone systems and space applications. Its products meet a steady need for indigenous sensors, optics and surveillance equipment.
What to watch: Track new order wins in optics and the progress of its newer product lines such as anti-drone and space-grade systems.
Why Apollo Hospitals Enterprise Features Among These Engineering Plastic, Defence and Hospital Stocks
Among the three companies on this list, Apollo Hospitals Enterprise is India’s largest private healthcare group, running a network of hospitals along with a pharmacy chain, diagnostics, primary care clinics and a digital health platform.
The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P/E of 51.0, below the industry P/E of 59.6.
Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore.
Roadmap: The company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.
What to watch: Track bed additions and occupancy and the growth of the pharmacy and digital health businesses.
Shaily Engineering Plastics vs Paras Defence and Space Technologies vs Apollo Hospitals Enterprise on Key Financials
The table below sets the three engineering plastic, defence and hospital stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Shaily Engineering Plastics | 577 | 998 | 14.7% | 170 | 17.0% |
| Paras Defence and Space Technologies | 186 | 493 | 27.6% | 89.5 | 18.2% |
| Apollo Hospitals Enterprise | 14,741 | 25,420 | 14.6% | 2,003 | 7.9% |
Shaily Engineering Plastics posts the highest return on equity in this group at 23.7%. Apollo Hospitals Enterprise has the largest FY26 revenue at Rs 25,420 crore, and Paras Defence and Space Technologies shows the fastest revenue growth with a 27.6% compound annual rate. A useful habit with engineering plastic, defence and hospital stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several plastic components, defence technology and hospitals stocks instead of one name, which keeps a single result from deciding the outcome.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Shaily Engineering Plastics | 249 | 281 | 12.9% |
| Paras Defence and Space Technologies | 95.6 | 130 | 35.9% |
| Apollo Hospitals Enterprise | 5,882 | 7,092 | 20.6% |
Key Risks to Check Before Investing in Engineering Plastic, Defence and Hospital Stocks
Every theme carries risks that deserve a check before any decision. For these engineering plastic, defence and hospital stocks, the main points are: Long-term polymer parts, optics maker and healthcare group shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio. Tracking promoter holding and management commentary adds context when you study polymer parts, optics maker and healthcare group shares.
- Production cycles. Vehicle output can vary with demand.
- Order timing. Defence and space orders can shift between periods.
- Capacity ramp up. New hospitals take time to fill beds and reach full returns.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter engineering plastic, defence and hospital stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Engineering Plastic, Defence and Hospital Stocks
Engineering plastic, defence and hospital stocks suit investors who prefer to study business strength before price moves. Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise each have a clear plan to grow. Based on the 12 November 2026 close, Shaily Engineering Plastics trades at Rs 3,123.8, Paras Defence and Space Technologies at Rs 1,304.4 and Apollo Hospitals Enterprise at Rs 8,515. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these engineering plastic, defence and hospital stocks to a watchlist. Peer comparison is the simplest way to judge engineering plastic, defence and hospital stocks, because sector averages show whether a company’s margins and returns are ordinary or exceptional.
Download the Univest iOS App or Univest Android App to track engineering plastic, defence and hospital stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are engineering plastic, defence and hospital stocks?
Ans. Engineering plastic, defence and hospital stocks are listed companies that make engineered plastic parts for vehicles and appliances, build optics and electronics for defence and space programmes, and run large hospitals, clinics and pharmacies. Their earnings depend on vehicle and appliance demand, defence orders and patient volumes. This list looks at three of them, Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise, using reported FY22 to FY26 financials and the 12 November 2026 closing prices.
Which engineering plastic, defence and hospital stocks are covered in this list?
Ans. This list covers Shaily Engineering Plastics, Paras Defence and Space Technologies and Apollo Hospitals Enterprise. Based on the 12 November 2026 close, Shaily Engineering Plastics traded at Rs 3,123.8, Paras Defence and Space Technologies at Rs 1,304.4 and Apollo Hospitals Enterprise at Rs 8,515. Their return on equity ranges from 12.1% to 23.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.6% to 27.6%.
Why do engineering plastic, defence and hospital stocks have a strong future roadmap in India?
Ans. Engineering plastic, defence and hospital stocks have a strong roadmap in India because growing use of engineered plastics, rising defence and space spending and strong demand for quality hospital care keep widening the market for these companies. The main drivers are as follows. Engineering plastics. Makers replace metal with light parts. Defence optics. Programmes need advanced domestic systems. Hospitals. Families seek quality specialist care. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Shaily Engineering Plastics performed financially?
Ans. Revenue rose from Rs 577 crore in FY22 to Rs 998 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 35.3 crore in FY22 to Rs 170 crore in FY26, which works out to a compound annual growth rate of 48.2%. In the June 2026 quarter, revenue grew 12.9% year on year to Rs 281 crore, while net profit rose 16.8% to Rs 48.0 crore. The company has a return on equity of 23.7%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 13,693 crore. The stock trades at a P/E of 77.5, above the industry P/E of 35.6. Looking ahead, the company is expanding in healthcare and consumer components, where global brands outsource complex moulding to trusted makers. Added capacity and new customer programmes support its order flow.
How has Paras Defence and Space Technologies performed financially?
Ans. Revenue rose from Rs 186 crore in FY22 to Rs 493 crore in FY26, a compound annual growth rate of 27.6%. Net profit grew from Rs 27.1 crore in FY22 to Rs 89.5 crore in FY26, which works out to a compound annual growth rate of 34.8%. In the June 2026 quarter, revenue grew 35.9% year on year to Rs 130 crore, while net profit rose 45.3% to Rs 20.7 crore. The company has a return on equity of 12.1%, a debt to equity ratio of 0.04 and a market capitalisation of Rs 10,193 crore. The stock trades at a P/E of 106.3, above the industry P/E of 48.1. Looking ahead, the company is among the few Indian private players in defence optics and has been adding capabilities in thermal imaging, anti-drone systems and space applications. Its products meet a steady need for indigenous sensors, optics and surveillance equipment.
How has Apollo Hospitals Enterprise performed financially?
Ans. Revenue rose from Rs 14,741 crore in FY22 to Rs 25,420 crore in FY26, a compound annual growth rate of 14.6%. Net profit grew from Rs 1,101 crore in FY22 to Rs 2,003 crore in FY26, which works out to a compound annual growth rate of 16.1%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 7,092 crore, while net profit rose 38.4% to Rs 610 crore. The company has a return on equity of 20.5%, a debt to equity ratio of 0.90 and a market capitalisation of Rs 110,757 crore. The stock trades at a P/E of 51.0, below the industry P/E of 59.6. Looking ahead, the company is adding hospital beds in proven cities while growing its pharmacy and digital businesses, which broaden its reach beyond inpatient care. A strong brand in complex treatment and a wide patient base support steady occupancy.
What risks should investors check before buying engineering plastic, defence and hospital stocks?
Ans. Investors should check a few risks before buying engineering plastic, defence and hospital stocks. Production cycles. Vehicle output can vary with demand. Order timing. Defence and space orders can shift between periods. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of engineering plastic, defence and hospital stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 12 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.